Pricing Log in Create free account

Akanda Corp. (AKAN) vs BioXcel Therapeutics, Inc. (BTAIQ)

Akanda Corp. and BioXcel Therapeutics, Inc. are both Drug Manufacturers Specialty & Generic companies. Akanda Corp. is the larger, with a market value of $3.5M against $2.3M — 1.5× the size. Across the 8 metrics below, Akanda Corp. leads on 5 and BioXcel Therapeutics, Inc. on 3.

Valuation

Metric AKAN BTAIQ Drug Manufacturers Specialty & Generic median
P/E — n/m 19.25
P/S n/m 1.23 2.11
P/B n/m n/m 1.78
Price to free cash flow n/m n/m 16.14
EV/EBITDA n/m n/m 12.58
EV/Sales n/m 228.32 2.73
Earnings yield — (12,633.33%) (4.38%)
Free cash flow yield 0.00% (5,602.20%) 0.00%

Profitability

Metric AKAN BTAIQ Drug Manufacturers Specialty & Generic median
Gross margin — 53.10% 53.94%
Operating margin — (6,054.72%) 0.00%
Net margin — (9,549.87%) 0.00%
Free cash flow margin 0.00% (6,860.38%) 0.00%
Return on equity 0.00% 63.52% (0.40%)
Return on assets 0.00% (259.62%) (3.32%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric AKAN BTAIQ Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — (14.52%) 10.01%
EPS growth (last fiscal year) (139.63%) 75.63% 49.06%
Revenue growth, 5-year CAGR 161.77% — 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AKAN BTAIQ Drug Manufacturers Specialty & Generic median
Debt to equity (0.70) (0.90) 0.05
Current ratio 0.22 0.21 2.31
Net debt to EBITDA (2.75) (1.61) 0.97

Dividend

Metric AKAN BTAIQ Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.57%
Payout ratio — — 0.27

Size

Metric AKAN BTAIQ Drug Manufacturers Specialty & Generic median
Market cap 3.45m 2.31m 276.90m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack